Latest Articles

Correction to: The role of purinergic P2X3 receptors and endometriosis-associated hyperalgesia.

Randomized, controlled, proof-of-concept trial of gefapixant for endometriosis-related pain.

To evaluate the P2X3 receptor antagonist, gefapixant, for treating moderate-to-severe endometriosis-related pain.